חזרה לתוצאות החיפוש

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Advanced/Metastatic Solid Tumors · Colorectal Cancer · Gastric Cancer · Gastroesophageal-junction Cancer · NSCLC · HNSCC · Head and Neck Squamous Cell Carcinoma · Esophageal Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • UCSD, La Jolla, California, United States

    Contact: Study coordinator (Petrea Monson) · 858-246-5674

  • USC Norris Comprehensive Cancer Center, Los Angeles, California, United States

    Contact: Study coordinator (Sandy Tran) · 323-865-3935

  • Sharp Healthcare, San Diego, California, United States

    Contact: Study coordinator (Danica Griffin)

  • Rocky Mountain Cancer Centers, Lone Tree, Colorado, United States

    Contact: Study coordinator (Jennifer Hege)

  • Florida Cancer Specialists, Fort Myers, Florida, United States

    Contact: Study coordinator (Sufficient Bien) · 941-907-4737

  • Sarah Cannon Research Institute (Lake Nona), Orlando, Florida, United States

    Contact: Study coordinator (Ingrid Acker) · 689-216-8500

  • Massachusetts General Hospital - Dana Farber, Boston, Massachusetts, United States

    Contact: Study coordinator (Rowan Cutler)

  • SSM Health Saint Louis University Hospital, St Louis, Missouri, United States

    Contact: Study coordinator (Cynthia Cantrell) · cynthia.cantrell@health.slu.edu

  • Washington University School of Medicine at St Louis, St Louis, Missouri, United States

    Contact: Study coordinator (Olive Pressey)

  • Cayuga Medical Center, Ithaca, New York, United States

    Contact: Study coordinator (Danielle Rao)

  • Hematology-Oncology Associates of Central New York, Syracuse, New York, United States

    Contact: Study coordinator (Kimberly Desimone)

  • Cleveland Clinic, Cleveland, Ohio, United States

    Contact: Study coordinator (Anil Timur) · timura@ccf.org

  • Taylor Cancer Research Center, Maumee, Ohio, United States

    Contact: Study coordinator (Stephanie Ambrose)

  • SSM OKC Hightower Clinical, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Caitlin Merrick) · 405-464-7300

  • The University Of Tennessee Health Science Center, Memphis, Tennessee, United States

    Contact: Study coordinator (Thomas Kerby) · tkerby@uthsc.edu

  • Sarah Cannon Research Institute, Nashville, Tennessee, United States

  • Texas Oncology, Dallas, Texas, United States

    Contact: Study coordinator (Collin Basham) · Collin.basham@usoncology.com

  • Oncology Consultants, Houston, Texas, United States

    Contact: Study coordinator (Carlos Cortez) · 713-600-0978

  • Texas Oncology, Tyler, Texas, United States

    Contact: Study coordinator (Kim Chadwick) · kim.chadwick@usoncology.com

  • Utah Cancer Specialists, Salt Lake City, Utah, United States

    Contact: Study coordinator (Emra Kazic) · studies@utahcancer.com

  • University of Utah Health Huntsman Cancer Hospital, Salt Lake City, Utah, United States

    Contact: Study coordinator (Devin Baxter) · 801-587-4767

  • Oncology & Hematology Associates of Southwest Virginia, Roanoke, Virginia, United States

    Contact: Study coordinator (Monica Sarp) · monica.sarp@usoncology.com

  • Cancer Care Northwest, Spokane, Washington, United States

    Contact: Study coordinator (Krystal Swenson) · 509-228-1682

  • Cliniques universitaires Saint-Luc, Brussels, Belgium

    Contact: Study coordinator (Roxane Watterman)

  • Institut Jules Bordet, Brussels, Belgium

    Contact: Study coordinator (Sophie Coutinho-Coelho)

  • UZ Gent, Ghent, Belgium

    Contact: Study coordinator (Ellen De Bruycker, MD)

  • Chu Ucl Namur Site De Sainte-Elisabeth, Namur, Belgium

    Contact: Study coordinator (Dominique Crasson)

  • Hopital Saint Andre, CHU Bordeaux, Bordeaux, France

    Contact: Study coordinator (Delphine Padenon)

  • Centre Leon Berard, Lyon, France

    Contact: Study coordinator (Martin Porret)

  • Hopital La Timone, Marseille, France

    Contact: Study coordinator (Leyla Ameur, MD)

  • Institut Régional du Cancer de Montpellier, Montpellier, France

    Contact: Study coordinator (Justine Rochet)

  • Centre Antoine Lacassagne, Nice, France

    Contact: Study coordinator (Morgane Sgorlon)

  • Institut Curie, Paris, France

    Contact: Study coordinator (Lucas Frezouls)

  • Institut Gustave Roussy, Paris, France

    Contact: Study coordinator (Thinhinane Ould Taleb)

  • Centre Henri Becquerel, Rouen, France

    Contact: Study coordinator (Amelie Poullain)

  • NKI - Antoni van Leeuwenhoek, Amsterdam, Netherlands

    Contact: Study coordinator (Lotte Heimans)

  • UMC Radboud, Nijmegen, Netherlands

    Contact: Study coordinator (Mirte Meijerinck)

  • UMC Utrecht, Utrecht, Netherlands

    Contact: Study coordinator (Sanne Bouwhuis)

  • Vall d'Hebron, Barcelona, Spain

    Contact: Study coordinator (Antonio Molina)

  • Hospital 12 de Octubre, Madrid, Spain

    Contact: Study coordinator (Marta Gutierrez) · Unidadfase1.imas12@h12o.es

  • Clinica Universidad de Navarra, Pamplona, Spain

    Contact: Study coordinator (Mercedes Egana)

  • Hospital Universitario de Navarra, Pamplona, Spain

    Contact: Study coordinator (Teresa Prieto)

  • Instituto Valenciano de Oncologia, Valencia, Spain

    Contact: Study coordinator (Laura Bailach) · datamanager38@fincivo.org

  • Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

  • Sarah Cannon Research Institute, London, United Kingdom

    Contact: Study coordinator (Valentina Achugo)
מובילי המחקר

  • Gianluca Laus, MD

    Study Director

    Merus B.V.

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)